Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity
Abstract Oncogene amplification is a key driver of cancer pathogenesis. Both breakage fusion bridge (BFB) cycles and extrachromosomal DNA (ecDNA) can lead to high oncogene copy numbers, but the impact of BFB amplifications on intratumoral heterogeneity, treatment response, and patient survival remai...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Online Access: | https://doi.org/10.1038/s41467-025-56670-8 |
